{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:18:45Z","timestamp":1791839925145,"version":"4.3.4"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12016-017-8627-2","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T11:02:49Z","timestamp":1501153369000},"page":"291-305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["The Cutaneous Spectrum of Lupus Erythematosus"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0098-1406","authenticated-orcid":false,"given":"Simone","family":"Ribero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savino","family":"Sciascia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Borradori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lipsker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"issue":"9","key":"8627_CR1","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1177\/0961203310370048","volume":"19","author":"G Obermoser","year":"2010","unstructured":"Obermoser G, Sontheimer RD, Zelger B (2010) Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus 19(9):1050\u20131070. doi: 10.1177\/0961203310370048","journal-title":"Lupus"},{"issue":"5","key":"8627_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.clindermatol.2006.07.014","volume":"24","author":"N Rothfield","year":"2006","unstructured":"Rothfield N, Sontheimer RD, Bernstein M (2006) Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol 24(5):348\u2013362. doi: 10.1016\/j.clindermatol.2006.07.014","journal-title":"Clin Dermatol"},{"key":"8627_CR3","doi-asserted-by":"crossref","unstructured":"Montoya-Ortiz G (2013) Immunosenescence, aging, and systemic lupus erythematous. Autoimmune Dis; 2013:267078. doi: 10.1155\/2013\/267078","DOI":"10.1155\/2013\/267078"},{"issue":"6","key":"8627_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jaad.2010.06.018","volume":"65","author":"A Kuhn","year":"2011","unstructured":"Kuhn A, Ruland V, Bonsmann G (2011) Cutaneous lupus erythematosus: update of therapeutic options part I. J Am Acad Dermatol 65(6):179\u2013193. doi: 10.1016\/j.jaad.2010.06.018","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"8627_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/archdermatol.2009.21","volume":"145","author":"O Durosaro","year":"2009","unstructured":"Durosaro O, Davis MD, Reed KB, Rohlinger AL (2009) Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study. Arch Dermatol 145(3):249\u2013253. doi: 10.1001\/archdermatol.2009.21","journal-title":"Arch Dermatol"},{"issue":"6","key":"8627_CR6","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","volume":"164","author":"CM Gronhagen","year":"2011","unstructured":"Gronhagen CM, Fored CM, Granath F, Nyberg F (2011) Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol 164(6):1335\u20131341. doi: 10.1111\/j.1365-2133.2011.10272.x","journal-title":"Br J Dermatol"},{"issue":"6","key":"8627_CR7","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/acr.22502","volume":"67","author":"S Jarukitsopa","year":"2015","unstructured":"Jarukitsopa S, Hoganson DD, Crowson CS, Sokumbi O, Davis MD, Michet CJ Jr, Matteson EL, Maradit Kremers H, Chowdhary VR (2015) Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States. Arthritis Care Res (Hoboken) 67(6):817\u2013828. doi: 10.1002\/acr.22502","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"8627_CR8","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai A-M, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677\u20132686. doi: 10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"issue":"12","key":"8627_CR9","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1001\/archderm.136.12.1508","volume":"136","author":"DM Lipsker","year":"2000","unstructured":"Lipsker DM, Schreckenberg-Gilliot C, Uring-Lambert B, Meyer A, Hartmann D, Grosshans EM, Hauptmann G (2000) Lupus erythematosus associated with genetically determined deficiency of the second component of the complement. Arch Dermatol 136(12):1508\u20131514","journal-title":"Arch Dermatol"},{"issue":"6","key":"8627_CR10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nm.2752","volume":"18","author":"Z Liu","year":"2012","unstructured":"Liu Z, Davidson A (2012) Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 18(6):871\u2013882. doi: 10.1038\/nm.2752","journal-title":"Nat Med"},{"issue":"12","key":"8627_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrrheum.2010.176","volume":"6","author":"Y Deng","year":"2010","unstructured":"Deng Y, Tsao BP (2010) Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 6(12):683\u2013692. doi: 10.1038\/nrrheum.2010.176","journal-title":"Nat Rev Rheumatol"},{"key":"8627_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/sj.gene.6364408","volume":"8","author":"TB Niewold","year":"2007","unstructured":"Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK (2007) High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 8:492\u2013502. doi: 10.1038\/sj.gene.6364408","journal-title":"Genes Immun"},{"key":"8627_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/ar3349","volume":"13","author":"N Jacob","year":"2011","unstructured":"Jacob N, Stohl W (2011) Cytokine disturbances in systemic lupus erythematosus. Arthritis Res Ther 13:228. doi: 10.1186\/ar3349","journal-title":"Arthritis Res Ther"},{"key":"8627_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1365-2133.2012.10813.x","volume":"167","author":"V T\u00fcngler","year":"2012","unstructured":"T\u00fcngler V, Silver RM, Walkenhorst H, G\u00fcnther C, Lee-Kirsch MA (2012) Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Gouti\u00e8res syndrome. Br J Dermatol 167:212\u2013214. doi: 10.1111\/j.1365-2133.2012.10813.x","journal-title":"Br J Dermatol"},{"issue":"47","key":"8627_CR15","doi-asserted-by":"publisher","first-page":"32548","DOI":"10.1074\/jbc.M114.547331","volume":"289","author":"T Miyazaki","year":"2014","unstructured":"Miyazaki T, Kim YS, Yoon J, Wang H, Suzuki T, Morse H (2014) The 3\u2032-5\u2032 DNA exonuclease TREX1 directly interacts with poly(ADP-ribose) polymerase-1 (PARP1) during the DNA damage response. J Biol Chem 289(47):32548\u201332558. doi: 10.1074\/jbc.M114.547331","journal-title":"J Biol Chem"},{"key":"8627_CR16","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/jid.2011.101","volume":"131","author":"A Kuhn","year":"2011","unstructured":"Kuhn A, Wozniacka A, Szepietowski J, Gl\u00e4ser R, Lehmann P, Haust M, Sysa-Jedrzejowska A, Reich A, Oke V, H\u00fcgel R, Calderon C, de Vries DE, Nyberg F et al (2011) Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol. J Invest Dermatol 131:1622\u20131630. doi: 10.1038\/jid.2011.101","journal-title":"J Invest Dermatol"},{"issue":"1","key":"8627_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/phpp.12018","volume":"29","author":"A Kim","year":"2013","unstructured":"Kim A, Chong BF (2013 Feb) Photosensitivity in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed 29(1):4\u201311. doi: 10.1111\/phpp.12018","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"8627_CR18","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1111\/1523-1747.ep12355594","volume":"100","author":"P Kind","year":"1993","unstructured":"Kind P, Lehmann P, Plewig G (1993) Phototesting in lupus erythematosus. J Invest Dermatol 100:53S\u201357S","journal-title":"J Invest Dermatol"},{"issue":"12","key":"8627_CR19","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1177\/0961203311409267","volume":"20","author":"S Freutel","year":"2011","unstructured":"Freutel S, Gaffal E, Zahn S, Bieber T, T\u00fcting T, Wenzel J (2011) Enhanced CCR5+\/CCR3+ T helper cell ratio in patients with active cutaneous lupus erythematosus. Lupus 20(12):1300\u20131304. doi: 10.1177\/0961203311409267","journal-title":"Lupus"},{"key":"8627_CR20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0190-9622(81)80261-7","volume":"4","author":"JN Gilliam","year":"1981","unstructured":"Gilliam JN, Sontheimer RD (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 4:471\u2013475","journal-title":"J Am Acad Dermatol"},{"key":"8627_CR21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0307-742X(21)00208-3","volume":"8","author":"JN Gilliam","year":"1982","unstructured":"Gilliam JN, Sontheimer RD (1982) Skin manifestations of SLE. Clin Rheum Dis 8:207\u2013218","journal-title":"Clin Rheum Dis"},{"key":"8627_CR22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/sj.jid.2009.42","volume":"129","author":"RD Sontheimer","year":"2009","unstructured":"Sontheimer RD (2009) Lichenoid tissue reaction\/interface dermatitis: clinical and histological perspectives. J Invest Dermatol 129:1088\u20131099. doi: 10.1038\/sj.jid.2009.42","journal-title":"J Invest Dermatol"},{"key":"8627_CR23","volume-title":"Histopathological diagnosis of inflammatory skin diseases","author":"AB Ackerman","year":"2005","unstructured":"Ackerman AB, Boer A, Benin B, Gottlieb GJ (2005) Histopathological diagnosis of inflammatory skin diseases, 3rd edn. Ardor Scribendi, New York","edition":"3"},{"key":"8627_CR24","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1177\/0961203310370044","volume":"19","author":"D Lipsker","year":"2010","unstructured":"Lipsker D (2010) The need to revisit the nosology of cutaneous lupus erythematosus: the current terminology and morphologic classification of cutaneous LE: difficult, incomplete and not always applicable. Lupus 19:1047\u20131049. doi: 10.1177\/0961203310370044","journal-title":"Lupus"},{"key":"8627_CR25","first-page":"59","volume-title":"Cutaneous lupus erythematosus","author":"A Kuhn","year":"2004","unstructured":"Kuhn A, Lehmann P, Ruzicka T (2004) Clinical manifestations of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Heidelberg, pp 59\u201392"},{"key":"8627_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.autrev.2005.01.003","volume":"4","author":"VP Werth","year":"2005","unstructured":"Werth VP (2005) Clinical manifestations of cutaneous lupus erythematosus. Autoimmun Rev 4:296\u2013302. doi: 10.1016\/j.autrev.2005.01.003","journal-title":"Autoimmun Rev"},{"issue":"11","key":"8627_CR27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archderm.1983.01650350011006","volume":"119","author":"MI Jacobs","year":"1983","unstructured":"Jacobs MI, Schned ES, Bystryn JC (1983) Variability of the lupus band test. Results in 18 patients with systemic lupus erythematosus. Arch Dermatol 119(11):883\u2013889","journal-title":"Arch Dermatol"},{"issue":"5","key":"8627_CR28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-4362.1995.tb03613.x","volume":"34","author":"AS al-Fouzan","year":"1995","unstructured":"al-Fouzan AS, Hassab-el-Naby HM, Dvorak R (1995) How reliable is the basement membrane phenomenon in the diagnosis of systemic lupus erythematosus? Int J Dermatol 34(5):330\u2013332","journal-title":"Int J Dermatol"},{"issue":"3","key":"8627_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1365-2230.2004.01520.x","volume":"29","author":"AM Alahlafi","year":"2004","unstructured":"Alahlafi AM, Wordsworth P, Wojnarowska F (2004) The distribution of IgG subclasses in the lupus band suggests disease-specific alteration in subclass switching rather than polyclonal B-cell activation. Clin Exp Dermatol 29(3):288\u2013292. doi: 10.1111\/j.1365-2230.2004.01520.x","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"8627_CR30","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archderm.1983.01650360056014","volume":"119","author":"MV Dahl","year":"1983","unstructured":"Dahl MV (1983) Usefulness of direct immunofluorescence in patients with lupus erythematosus. Arch Dermatol 119(12):1010\u20131017","journal-title":"Arch Dermatol"},{"key":"8627_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1067\/mjd.2001.114589","volume":"45","author":"A Kuhn","year":"2001","unstructured":"Kuhn A, Sonntag M, Richter-Hintz D, Oslislo C, Megahed M, Ruzicka T, Lehmann P (2001) Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol 45:86\u201395. doi: 10.1067\/mjd.2001.114589","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"8627_CR32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archderm.1990.01670250058008","volume":"126","author":"MS Jerdan","year":"1990","unstructured":"Jerdan MS, Hood AF, Moore GW, Callen JP (1990) Histopathologic comparison of the subsets of lupus erythematosus. Arch Dermatol 126(1):52\u201355","journal-title":"Arch Dermatol"},{"issue":"3","key":"8627_CR33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archderm.1984.01650390054011","volume":"120","author":"JL Bangert","year":"1984","unstructured":"Bangert JL, Freeman RG, Sontheimer RD, Gilliam JN (1984) Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings. Arch Dermatol 120(3):332\u2013337","journal-title":"Arch Dermatol"},{"issue":"5","key":"8627_CR34","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1365-2133.2001.04182.x","volume":"144","author":"B Baima","year":"2001","unstructured":"Baima B, Sticherling M (2001) Apoptosis in different cutaneous manifestations of lupus erythematosus. Br J Dermatol 144(5):958\u2013966","journal-title":"Br J Dermatol"},{"issue":"2","key":"8627_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2133.2004.06308.x","volume":"152","author":"P Boeckler","year":"2005","unstructured":"Boeckler P, Milea M, Meyer A, Uring-Lambert B, Heid E, Hauptmann G, Cribier B, Lipsker D (2005) The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2\/C4 deficiency. Br J Dermatol 152(2):265\u2013270. doi: 10.1111\/j.1365-2133.2004.06308.x","journal-title":"Br J Dermatol"},{"key":"8627_CR36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/0001555577305308","volume":"77","author":"B Tebbe","year":"1997","unstructured":"Tebbe B, Mansmann U, Wollina U, Auer-Grumbach P, Licht-Mbalyohere A, Arsenmeier M, Orfanos CE (1997) Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol 77:305\u2013308","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"8627_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0560.2001.280101.x","volume":"28","author":"AN Crowson","year":"2001","unstructured":"Crowson AN, Magro C (2001) The cutaneous pathology of lupus erythematosus: a review. J Cutan Pathol 28(1):1\u201323","journal-title":"J Cutan Pathol"},{"issue":"3","key":"8627_CR38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-4362.1998.00288.x","volume":"37","author":"K Kulthanan","year":"1998","unstructured":"Kulthanan K, Pinkaew S, Suthipinittharm P (1998) Diagnostic value of IgM deposition at the dermo-epidermal junction. Int J Dermatol 37(3):201\u2013205","journal-title":"Int J Dermatol"},{"key":"8627_CR39","doi-asserted-by":"crossref","unstructured":"Chanprapaph K, Sawatwarakul S, Vachiramon V. (2017) A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients. Lupus 961203317699714. doi: 10.1177\/0961203317699714","DOI":"10.1177\/0961203317699714"},{"issue":"2","key":"8627_CR40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jaad.2007.09.039","volume":"58","author":"V R\u00e9my-Leroux","year":"2008","unstructured":"R\u00e9my-Leroux V, L\u00e9onard F, Lambert D, Wechsler J, Cribier B, Thomas P, Adamski H, Marguery MC, Aubin F, Leroy D, Bernard P (2008) Comparison of histopathologic-clinical characteristics of Jessner's lymphocytic infiltration of the skin and lupus erythematosus tumidus: multicenter study of 46 cases. J Am Acad Dermatol 58(2):217\u2013223. doi: 10.1016\/j.jaad.2007.09.039","journal-title":"J Am Acad Dermatol"},{"key":"8627_CR41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.136.8.1033","volume":"136","author":"A Kuhn","year":"2000","unstructured":"Kuhn A, Richter-Hintz D, Oslislo C, Ruzicka T, Megahed M, Lehmann P (2000) Lupus erythematosus tumidus\u2014a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol 136:1033\u20131041","journal-title":"Arch Dermatol"},{"key":"8627_CR42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0190-9622(91)70040-9","volume":"24","author":"F Rongioletti","year":"1991","unstructured":"Rongioletti F, Rebora A (1991) The new cutaneous mucinoses. A review with an up-to-date classification of cutaneous mucinoses. J Am Acad Dermatol 24:265\u2013270","journal-title":"J Am Acad Dermatol"},{"key":"8627_CR43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5070\/D331N863FR","volume":"10","author":"VG Ortiz","year":"2004","unstructured":"Ortiz VG, Krishnan RS, Chen LL, Hsu S (2004) Papulonodular mucinosis in systemic lupus erythematosus. Dermatol Online J 10:16","journal-title":"Dermatol Online J"},{"key":"8627_CR44","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2133.1954.tb12574.x","volume":"66","author":"SC Gold","year":"1954","unstructured":"Gold SC (1954) An unusual papular eruption associated with lupus erythematosus. Br J Dermatol 66:429\u2013433","journal-title":"Br J Dermatol"},{"issue":"2","key":"8627_CR45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1191\/096120300678828028","volume":"9","author":"J Pozo Del","year":"2000","unstructured":"Del Pozo J, Pe\u00f1a C, Almagro M, Yebra MT, Mart\u00ednez W, Fonseca E (2000) Systemic lupus erythematosus presenting with a reticular erythematous mucinosis-like condition. Lupus 9(2):144\u2013146. doi: 10.1191\/096120300678828028","journal-title":"Lupus"},{"issue":"1","key":"8627_CR46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.berh.2016.04.002","volume":"30","author":"M Khamashta","year":"2016","unstructured":"Khamashta M, Taraborelli M, Sciascia S, Tincani A (2016) Antiphospholipid syndrome. Best Pract Res Clin Rheumatol 30(1):133\u2013148. doi: 10.1016\/j.berh.2016.04.002","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"8627_CR47","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/art.21041","volume":"52","author":"C Franc\u00e8s","year":"2005","unstructured":"Franc\u00e8s C, Niang S, Laffitte E, Fl P, Costedoat N, Piette JC (2005) Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum 52(6):1785\u20131793. doi: 10.1002\/art.21041","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8627_CR48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/0394632015582344","volume":"28","author":"S Caporuscio","year":"2015","unstructured":"Caporuscio S, Sorgi ML, Nistic\u00f2 S, Pranteda G, Bottoni U, Carboni I, Del Duca E, Pranteda G (2015) Cutaneous manifestations in antiphospholipid syndrome. Int J Immunopathol Pharmacol 28(2):270\u2013273. doi: 10.1177\/0394632015582344","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"4","key":"8627_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000113940","volume":"216","author":"D Lipsker","year":"2008","unstructured":"Lipsker D, Saurat JH (2008) Neutrophilic cutaneous lupus erythematosus. At the edge between innate and acquired immunity? Dermatology 216(4):283\u2013286. doi: 10.1159\/000113940","journal-title":"Dermatology"},{"issue":"29","key":"8627_CR50","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1097\/MD.0000000000000351","volume":"93","author":"L Gusdorf","year":"2014","unstructured":"Gusdorf L, Bessis D, Lipsker D (2014) Lupus erythematosus and neutrophilic urticarial dermatosis: a retrospective study of 7 patients. Medicine (Baltimore) 93(29):e351. doi: 10.1097\/MD.0000000000000351","journal-title":"Medicine (Baltimore)"},{"key":"8627_CR51","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1601-0825.2006.01292.x","volume":"12","author":"DI Mitsias","year":"2006","unstructured":"Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM (2006) Sj\u00f6gren\u2019s syndrome: why autoimmune epithelitis? Oral Dis 12:523\u2013532. doi: 10.1111\/j.1601-0825.2006.01292.x","journal-title":"Oral Dis"},{"key":"8627_CR52","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1346-8138.2005.tb00894.x","volume":"32","author":"W Fujimoto","year":"2005","unstructured":"Fujimoto W, Hamada T, Yamada J, Matsuura H, Iwatsuki K (2005) Bullous systemic lupus erythematosus as an initial manifestation of SLE. J Dermatol 32:1021\u20131027","journal-title":"J Dermatol"},{"key":"8627_CR53","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0190-9622(83)70210-0","volume":"9","author":"C Camisa","year":"1983","unstructured":"Camisa C, Sharma HM (1983) Vesiculobullous systemic lupus erythematosus. J Am Acad Dermatol 9:924\u2013933","journal-title":"J Am Acad Dermatol"},{"key":"8627_CR54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-97-2-165","volume":"197","author":"RP Hall","year":"1982","unstructured":"Hall RP, Lawley TJ, Smith HR, Katz SI (1982) Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy. Ann Intern Med 197:165\u2013170","journal-title":"Ann Intern Med"},{"issue":"4","key":"8627_CR55","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000113942","volume":"216","author":"AV Marzano","year":"2008","unstructured":"Marzano AV, Ramoni S, Caputo R (2008) Amicrobial pustulosis of the folds. Report of 6 cases and a literature review. Dermatology 216(4):305\u2013311. doi: 10.1159\/000113942","journal-title":"Dermatology"},{"key":"8627_CR56","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000329428","volume":"222","author":"HY Lee","year":"2011","unstructured":"Lee HY, Pelivani N, Beltraminelli H, Hegyi I, Yawalkar N, Borradori L (2011) Amicrobial pustulosis-like rash in a patient with Crohn\u2019s disease under anti-TNF-alpha blocker. Dermatology 222:304\u2013310. doi: 10.1159\/000329428","journal-title":"Dermatology"},{"key":"8627_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/MD.0b013e3181943f5e","volume":"88","author":"C Kieffer","year":"2009","unstructured":"Kieffer C, Cribier B, Lipsker D (2009) Neutrophilic urticarial dermatosis; a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine (Baltimore) 88:23\u201331. doi: 10.1097\/MD.0b013e3181943f5e","journal-title":"Medicine (Baltimore)"},{"issue":"29","key":"8627_CR58","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000351","volume":"93","author":"L Gusdorf","year":"2014","unstructured":"Gusdorf L, Bessis D, Lipsker D (2014) Lupus erythematosus and neutrophilic urticarial dermatosis: a retrospective study of 7 patients. Medicine (Baltimore) 93(29):e351. doi: 10.1097\/MD.0000000000000351","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"8627_CR59","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/MOP.0000000000000383","volume":"28","author":"AO Hersh","year":"2016","unstructured":"Hersh AO, Arkin LM, Prahalad S (2016) Immunogenetics of cutaneous lupus erythematosus. Curr Opin Pediatr 28(4):470\u2013475. doi: 10.1097\/MOP.0000000000000383","journal-title":"Curr Opin Pediatr"},{"key":"8627_CR60","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/acr.21966","volume":"65","author":"J Bourre-Tessier","year":"2013","unstructured":"Bourre-Tessier J, Peschken CA, Bernatsky S, Joseph L, Clarke AE, Fortin PR et al (2013) Association of smoking with cutaneous manifestations in systemic lupus erythematosus. Arthritis Care Res (Hoboken) 65:1275\u20131280. doi: 10.1002\/acr.21966","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8627_CR61","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/bjd.13006","volume":"171","author":"A Kuhn","year":"2014","unstructured":"Kuhn A, Sigges J, Biazar C, Ruland V, Patsinakidis N, Landmann A, Amler S, Bonsmann G, EUSCLE coauthors (2014) Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database. Br J Dermatol 171:571\u2013579. doi: 10.1111\/bjd.13006","journal-title":"Br J Dermatol"},{"key":"8627_CR62","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1136\/ard.2007.072587","volume":"66","author":"G Leroux","year":"2007","unstructured":"Leroux G, Costedoat-Chalumeau N, Hulot JS, Amoura Z, Frances C, Aymard G, Lechat P, Piette JC (2007) Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases. Ann Rheum Dis 66:1547\u20131548. doi: 10.1136\/ard.2007.072587","journal-title":"Ann Rheum Dis"},{"key":"8627_CR63","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.revmed.2004.07.005","volume":"25","author":"D Lardet","year":"2004","unstructured":"Lardet D, Martin S, Truchetet F, Cuny JF, Virion JM, Schmutz JL (2004) Effect of smoking on the effectiveness of antimalarial drugs for cutaneous lesions of patients with lupus: assessment in a prospective study. Rev Med Interne 25:786\u2013791. doi: 10.1016\/j.revmed.2004.07.005","journal-title":"Rev Med Interne"},{"issue":"6","key":"8627_CR64","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","volume":"123","author":"MF Marmor","year":"2016","unstructured":"Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF, American Academy of Ophthalmology (2016) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology 123(6):1386\u20131394. doi: 10.1016\/j.ophtha.2016.01.058","journal-title":"Ophthalmology"},{"issue":"1","key":"8627_CR65","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.2008.101766","volume":"69","author":"G Ruiz-Irastorza","year":"2010","unstructured":"Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA (2010) Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 69(1):20\u201328. doi: 10.1136\/ard.2008.101766","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8627_CR66","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/acr.20002","volume":"62","author":"G Schmajuk","year":"2010","unstructured":"Schmajuk G, Yazdany J, Trupin L, Yelin E (2010) Hydroxychloroquine use in a community-based cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 62(3):386\u2013392. doi: 10.1002\/acr.20002","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"8627_CR67","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/ard.2006.068676","volume":"66","author":"GS Alarc\u00f3n","year":"2007","unstructured":"Alarc\u00f3n GS, McGwin G, Bertoli AM, Fessler BJ, Calvo-Al\u00e9n J, Bastian HM, Vil\u00e1 LM, Reveille JD, LUMINA Study Group (2007) Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis 66(9):1168\u20131172. doi: 10.1136\/ard.2006.068676","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8627_CR68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1191\/096120300678828163","volume":"9","author":"DJ Wallace","year":"2000","unstructured":"Wallace DJ (2000) Is there a role for quinacrine (Atabrine) in the new millennium? Lupus 9(2):81","journal-title":"Lupus"},{"issue":"12","key":"8627_CR69","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1002\/art.24068","volume":"59","author":"PR Fortin","year":"2008","unstructured":"Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M, Canadian Network For Improved Outcomes in Systemic Lupus (2008) Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 59(12):1796\u20131804. doi: 10.1002\/art.24068","journal-title":"Arthritis Rheum"},{"issue":"7","key":"8627_CR70","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00128071-200304070-00002","volume":"4","author":"P Fabbri","year":"2003","unstructured":"Fabbri P, Cardinali C, Giomi B, Caproni M (2003) Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol 4(7):449\u2013465","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"8627_CR71","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.jaad.2016.01.054","volume":"74","author":"F Fennira","year":"2016","unstructured":"Fennira F, Chasset F, Soubrier M, Cordel N, Petit A, Franc\u00e8s C (2016) Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients. J Am Acad Dermatol 74(6):1248\u20131251. doi: 10.1016\/j.jaad.2016.01.054","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"8627_CR72","first-page":"41","volume":"32","author":"I Camara","year":"2014","unstructured":"Camara I, Sciascia S, Simoes J, Pazzola G, Salas V, Karim Y, Roccatello D, Cuadrado MJ (2014) Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre. Clin Exp Rheumatol 32(1):41\u201347","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"8627_CR73","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.berh.2013.07.002","volume":"27","author":"S Sciascia","year":"2013","unstructured":"Sciascia S, Cuadrado MJ, Karim MY (2013) Management of infection in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 27(3):377\u2013389. doi: 10.1016\/j.berh.2013.07.002","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"8627_CR74","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/jdv.14053","volume":"31","author":"A Kuhn","year":"2017","unstructured":"Kuhn A, Aberer E, Bata-Cs\u00f6rg\u0151 Z, Caproni M, Dreher A, Frances C, Gl\u00e4ser R, Kl\u00f6tgen HW, Landmann A, Marinovic B, Nyberg F, Olteanu R, Ranki A, Szepietowski JC, Volc-Platzer B (2017) S2k guideline for treatment of cutaneous lupus erythematosus\u2014guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 31(3):389\u2013404. doi: 10.1111\/jdv.14053","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"8627_CR75","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.autrev.2015.07.017","volume":"14","author":"D Roccatello","year":"2015","unstructured":"Roccatello D, Sciascia S, Baldovino S, Rossi D, Alpa M, Naretto C, Di Simone D, Simoncini M, Menegatti E (2015) A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-clinical response compared to literature and immunological re-assessment. Autoimmun Rev 14(12):1123\u20131130. doi: 10.1016\/j.autrev.2015.07.017","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8627_CR76","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.intimp.2015.04.049","volume":"27","author":"S Sciascia","year":"2015","unstructured":"Sciascia S, Talavera-Garcia E, Roccatello D, Baldovino S, Mengatti E, Cuadrado MJ (2015) Upcoming biological therapies in systemic lupus erythematosus. Int Immunopharmacol 27(2):189\u2013193. doi: 10.1016\/j.intimp.2015.04.049","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"8627_CR77","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/art.30613","volume":"63","author":"R Furie","year":"2011","unstructured":"Furie R, Petri M, Zamani O, Cervera R, Wallace DJ, Tegzov\u00e1 D, Sanchez-Guerrero J, Schwarting A, Merrill JT, Chatham WW, Stohl W, Ginzler EM, Hough DR, Zhong ZJ, Freimuth W, van Vollenhoven RF, BLISS-76 Study Group (2011) A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum 63(12):3918\u20133930. doi: 10.1002\/art.30613","journal-title":"Arthritis Rheum"},{"issue":"9767","key":"8627_CR78","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","volume":"377","author":"SV Navarra","year":"2011","unstructured":"Navarra SV, Guzm\u00e1n RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, Li EK, Thomas M, Kim HY, Le\u00f3n MG, Tanasescu C, Nasonov E, Lan JL, Pineda L, Zhong ZJ, Freimuth W, Petri MA, BLISS-52 Study Group (2011) Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377(9767):721\u2013723. doi: 10.1016\/S0140-6736(10)61354-2","journal-title":"Lancet"},{"key":"8627_CR79","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1177\/0961203309106176","volume":"18","author":"AV Marzano","year":"2009","unstructured":"Marzano AV, Vezzoli P, Crosti C (2009) Drug-induced lupus: an update on its dermatologic aspects. Lupus 18:935\u2013940. doi: 10.1177\/0961203309106176","journal-title":"Lupus"},{"key":"8627_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/14740338.2015.995089","volume":"2","author":"RL Rubin","year":"2015","unstructured":"Rubin RL (2015) Drug-induced lupus. Expert Opin Drug Saf 2:1\u201318. doi: 10.1517\/14740338.2015.995089","journal-title":"Expert Opin Drug Saf"},{"key":"8627_CR81","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00403-008-0895-5","volume":"301","author":"CD Vedove","year":"2009","unstructured":"Vedove CD, Del Giglio M, Schena D, Girolomoni G (2009) Drug-induced lupus erythematosus. Arch Dermatol Res 301:99\u2013105. doi: 10.1007\/s00403-008-0895-5","journal-title":"Arch Dermatol Res"},{"key":"8627_CR82","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaut.2014.01.005","volume":"48-49","author":"X Xiao","year":"2014","unstructured":"Xiao X, Chang C (2014) Diagnosis and classification of drug-induced autoimmunity (DIA). J Autoimmun 48-49:66\u201372. doi: 10.1016\/j.jaut.2014.01.005","journal-title":"J Autoimmun"},{"key":"8627_CR83","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.autrev.2010.07.005","volume":"10","author":"U Katz","year":"2010","unstructured":"Katz U, Zandman-Goddard G (2010) Drug-induced lupus: an update. Autoimmun Rev 10:46\u201350. doi: 10.1016\/j.autrev.2010.07.005","journal-title":"Autoimmun Rev"},{"issue":"6","key":"8627_CR84","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/096120339400300605","volume":"3","author":"MJ Fritzler","year":"1994","unstructured":"Fritzler MJ (1994) Drugs recently associated with lupus syndromes. Lupus 3(6):455\u2013459. doi: 10.1177\/096120339400300605","journal-title":"Lupus"},{"issue":"3","key":"8627_CR85","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0190-9622(98)70497-9","volume":"38","author":"E Chlebus","year":"1998","unstructured":"Chlebus E, Wolska H, Blaszczyk M, Jablonska S (1998) Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. J Am Acad Dermatol 38(3):405\u2013412","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"8627_CR86","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-2133.2011.10397.x","volume":"165","author":"AV Marzano","year":"2011","unstructured":"Marzano AV, Lazzari R, Polloni I, Crosti C, Fabbri P, Cugno M (2011) Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart. Br J Dermatol 165(2):335\u2013341. doi: 10.1111\/j.1365-2133.2011.10397.x","journal-title":"Br J Dermatol"},{"issue":"9","key":"8627_CR87","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/1529-0131(199709)","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. doi: 10.1002\/1529-0131(199709)","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8627_CR88","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2133.1997.tb14899.x","volume":"136","author":"F Nyberg","year":"1997","unstructured":"Nyberg F, Hasan T, Puska P, Stephansson E, H\u00e4kkinen M, Ranki A, Ros AM (1997) Occurrence of polymorphous light eruption in lupus erythematosus. Br J Dermatol 136(2):217\u2013221","journal-title":"Br J Dermatol"},{"issue":"9","key":"8627_CR89","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1177\/0961203310370344","volume":"19","author":"A Kuhn","year":"2010","unstructured":"Kuhn A, Ruland V, Bonsmann G (2010) Photosensitivity, phototesting, and photoprotection in cutaneous lupus erythematosus. Lupus 19(9):1036\u20131046. doi: 10.1177\/0961203310370344","journal-title":"Lupus"},{"issue":"2","key":"8627_CR90","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12016-013-8403-x","volume":"47","author":"A Kuhn","year":"2014","unstructured":"Kuhn A, Wenzel J, Weyd H (2014) Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review. Clin Rev Allergy Immunol 47(2):148\u2013162. doi: 10.1007\/s12016-013-8403-x","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"8627_CR91","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/phpp.12018","volume":"29","author":"A Kim","year":"2013","unstructured":"Kim A, Chong BF (2013) Photosensitivity in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed 29(1):4\u201311. doi: 10.1111\/phpp.12018","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"8627_CR92","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1196\/annals.1422.004","volume":"1108","author":"E Schmidt","year":"2007","unstructured":"Schmidt E, Tony H-P, Br\u00f6cker E-B, Kneitz C (2007) Sun-induced life-threatening lupus nephritis. Ann N Y Acad Sci 1108:35\u201340","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"8627_CR93","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.0022-202X.2005.23889.x","volume":"125","author":"J Albrecht","year":"2005","unstructured":"Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, Kantor J, Kim E, Militello G, McGinnis K, Richardson S, Treat J, Vittorio C, Van Voorhees A, Werth VP (2005) The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol 125(5):889\u2013894. doi: 10.1111\/j.0022-202X.2005.23889.x","journal-title":"J Invest Dermatol"},{"issue":"1","key":"8627_CR94","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2133.2010.09799","volume":"163","author":"A Kuhn","year":"2010","unstructured":"Kuhn A, Meuth AM, Bein D, Amler S, Beissert S, B\u00f6hm M, Brehler R, Ehrchen J, Grundmann S, Haust M, Ruland V, Schiller M, Schulz P, St\u00e4nder S, Sauerland C, K\u00f6pcke W, Luger TA, Bonsmann G (2010) Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus. Br J Dermatol 163(1):83\u201392. doi: 10.1111\/j.1365-2133.2010.09799","journal-title":"Br J Dermatol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-017-8627-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8627-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8627-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T20:38:50Z","timestamp":1719347930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-017-8627-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["8627"],"URL":"https:\/\/doi.org\/10.1007\/s12016-017-8627-2","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}